Cureline collects biospecimens from patients with all types of hematologic malignancies (ALL, AML, CLL, CML, MM, MDS, etc.) in the chronic and crisis stages of the disease. Cancer blood, bone marrow aspirate and bone marrow trephine biopsy specimens obtained from these patients are used for cellular and molecular analyses for drug discovery, preclinical research, drug safely evaluation, biomarker development and pre-selection of indications for clinical trials.
|
Cureline provides high-quality human specimens for biomedical research. Non-target specific binding to adult normal human tissues (cross-reactivity) is invistigated for all new therapeutic antibodies. Cureline offers services in procurement of normal tissues (sergical specimens and 3-12 h post-martem tissues) and cross-reactivity testing using immunohistochemical analysis (IHC).
|